People: Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

33.17USD
21 Nov 2014
Price Change (% chg)

$0.74 (+2.28%)
Prev Close
$32.43
Open
$32.80
Day's High
$33.24
Day's Low
$32.23
Volume
111,151
Avg. Vol
146,229
52-wk High
$37.74
52-wk Low
$23.90

Search Stocks

Baker, Felix 

Brief Biography

Dr. Felix J. Baker, Ph.D., is appointed as the Director of Genomic Health, Inc. Dr. Baker is a Managing Partner of Baker Brothers Investments, which he and his brother, Julian C. Baker, founded in 2000. Dr. Baker's firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Dr. Baker's career as a fund-manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker is also a director of Seattle Genetics, Inc., where he serves as lead independent director, and of Synageva, Inc. Dr. Baker served as a director of Ardea Biosciences, Inc. from February 2010 until its acquisition in June 2012, a director of Neurogen Corporation from May 1999 until July 2008, and a director of Trimeris, Inc. from April 2004 until November 2011. Dr. Baker holds a B.S. and Ph.D. in Immunology from Stanford University, where he also completed two years of medical school.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits

2,140,180

G. Bradley Cole

1,448,860

Steven Shak

1,300,320

Julian Baker

--

Henry Fuchs

--

Felix Baker

--
As Of 30 Dec 2013
Search Stocks